NHI Stock Cash Flow Statements

National Health Investors Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

National Health Investors Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-09-30	2011-06-30	2011-03-31	2010-03-31

cash flows from operating activities:
net income	36,689,000	33,817,000	42,787,000	28,242,000	34,953,000	30,657,000	31,719,000	29,032,000	39,447,000	34,183,000	1,560,000	34,229,000	21,466,000	8,246,000	6,505,000	30,849,000	39,229,000	35,384,000	37,163,000	42,660,000	44,426,000	61,062,000	42,036,000	42,756,000	39,978,000	35,679,000	37,082,000	40,980,000	37,839,000	38,432,000	37,799,000	39,091,000	38,245,000	44,230,000	41,188,000	33,438,000	44,981,000	33,109,000	54,786,000	33,977,000	31,538,000	30,013,000	28,100,000	25,518,000	25,578,000	23,856,000	28,110,000	43,051,000	20,098,000	15,923,000	41,270,000	14,350,000	16,928,000	18,350,000	18,808,000	25,117,000	19,093,000	15,943,000
adjustments to reconcile net income to net cash from operating activities:
depreciation	19,918,000	19,157,000	18,680,000	17,768,000	17,490,000	17,505,000	17,111,000	17,515,000	17,730,000	17,617,000	17,303,000	17,533,000	17,772,000	18,272,000	19,299,000	20,035,000	20,658,000	20,806,000	21,024,000	20,836,000	20,847,000	20,443,000	19,610,000	19,695,000	19,020,000	18,491,000	18,067,000	18,153,000	17,794,000	17,335,000	17,167,000	17,023,000	16,829,000	16,154,000	15,897,000	15,239,000	14,696,000	13,733,000	13,661,000	13,485,000	13,003,000	13,014,000	9,705,000	9,596,000	9,540,000	9,237,000	5,953,000	5,732,000	4,558,000	4,415,000	4,328,000	5,892,000	3,396,000	3,365,000	2,936,000	2,948,000	2,884,000	2,594,000
amortization of debt issuance costs, debt discount and prepaids
amortization of commitment fees and notes receivable discounts
amortization of lease incentives	725,000	725,000	725,000	722,000	723,000	723,000	723,000	723,000	776,000	299,000	78,000	58,000	7,167,000	252,000	252,000	252,000	262,000	260,000	252,000	250,000	249,000	236,000	238,000	224,000	215,000	168,000	147,000	108,000	69,000	63,000	50,000
straight-line rent adjustments				-1,161,000	-1,213,000	308,000		-1,039,000	-2,875,000	-2,097,000		-2,476,000
non-cash interest income on mortgage and other notes receivable	-412,000	-243,000	-85,000	-14,000	0	-25,000	0	-518,000	-408,000	-376,000	-1,058,000	-1,201,000	-1,175,000	-880,000	-1,263,000	-198,000	-453,000	-700,000	-974,000
gains on sales of real estate properties
gains from equity method investment	-1,524,000	-415,000	0	0	-236,000	-166,000								-297,000
loan and realty (gains) losses									186,000	-418,000								-50,000
non-cash share-based compensation expense
changes in operating assets and liabilities:
other assets	384,000	-711,000	-2,206,000	328,000	809,000	-3,631,000	-317,000	206,000	1,140,000	-3,772,000	679,000	-1,650,000	-2,456,000	-107,000	-912,000	-447,000	-2,207,000	-484,000	995,000	-93,000	-385,000	-357,000	-455,000	-415,000	-487,000	2,961,000	-1,634,000	2,095,000	-1,514,000	-4,245,000		-2,504,000	-1,664,000	-657,000
accounts payable and accrued expenses	4,108,000	-8,522,000	6,768,000	-2,208,000	6,248,000	-7,523,000	4,612,000	541,000	4,053,000	-3,277,000	2,980,000	-2,279,000	3,976,000	-4,252,000	5,943,000	-2,709,000	853,000	-735,000	-4,168,000	805,000	-1,821,000	-1,497,000	-1,457,000	186,000	-26,000	1,597,000	1,247,000								1,127,000	2,068,000	-922,000	491,000	1,094,000	948,000	2,286,000	-3,290,000	1,941,000	-670,000	1,326,000	-1,149,000	1,997,000	172,000	766,000	-440,000	200,000	-255,000	208,000	-665,000				-66,000
deferred income	-67,000	74,000	-187,000	-347,000	-174,000	-432,000	363,000	-66,000	23,000	-219,000	-300,000	789,000	308,000	-385,000	141,000	344,000	-173,000	-52,000	52,000	-406,000	756,000	-619,000	-81,000	707,000	-152,000	16,322,000									89,000	306,000	-537,000	-1,243,000	1,100,000	-171,000	-184,000	1,756,000	-301,000	-43,000	-286,000	-2,200,000	2,086,000	-45,000	-64,000	-40,000	-40,000	-269,000	10,000	-40,000	234,000	57,000	-38,000	401,000
net cash from operating activities	59,817,000	46,478,000	57,573,000	48,629,000	60,739,000	40,827,000	53,203,000	49,703,000	50,496,000	31,048,000	46,357,000	43,535,000	56,768,000	38,680,000	53,358,000	48,989,000	51,600,000	56,912,000	55,621,000	59,718,000	59,727,000	57,082,000	56,146,000	57,895,000	53,077,000	73,837,000	51,871,000	54,173,000	53,317,000	48,508,000	51,365,000	51,012,000	46,273,000	48,675,000	47,903,000	46,121,000	41,898,000	41,297,000	43,629,000	40,800,000	41,432,000	38,564,000	32,928,000	31,595,000	32,744,000	28,876,000	29,780,000	26,488,000	24,079,000	23,846,000	22,531,000	21,863,000	20,625,000	21,247,000	19,924,000	21,377,000	17,355,000	19,272,000
capex	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
free cash flows	59,817,000	46,478,000	57,573,000	48,629,000	60,739,000	40,827,000	53,203,000	49,703,000	50,496,000	31,048,000	46,357,000	43,535,000	56,768,000	38,680,000	53,358,000	48,989,000	51,600,000	56,912,000	55,621,000	59,718,000	59,727,000	57,082,000	56,146,000	57,895,000	53,077,000	73,837,000	51,871,000	54,173,000	53,317,000	48,508,000	51,365,000	51,012,000	46,273,000	48,675,000	47,903,000	46,121,000	41,898,000	41,297,000	43,629,000	40,800,000	41,432,000	38,564,000	32,928,000	31,595,000	32,744,000	28,876,000	29,780,000	26,488,000	24,079,000	23,846,000	22,531,000	21,863,000	20,625,000	21,247,000	19,924,000	21,377,000	17,355,000	19,272,000
cash flows from investing activities:
investments in mortgage and other notes receivable	-6,553,000	-19,135,000		-1,212,000	-10,600,000	-16,004,000		-20,930,000	-4,955,000	-7,219,000		-6,454,000	-8,016,000	-16,350,000		-12,051,000	-34,424,000	-8,412,000		-8,889,000	-12,528,000	-20,298,000		-24,291,000	-48,653,000	-11,002,000		-6,299,000	-3,940,000	-5,905,000		-13,779,000	-2,612,000	-28,338,000
collections on mortgage and other notes receivable
fees received on mortgage notes receivable
acquisitions of real estate properties
proceeds from sales of real estate properties
investments in renovations of existing real estate properties and equipment
distributions received from equity method investment
net cash from investing activities	-48,316,000	-75,469,000	-161,199,000	-1,572,000	-13,351,000	-16,193,000	2,336,000	-19,946,000	33,501,000	-27,521,000	-49,198,000	54,920,000	194,283,000	-2,060,000	21,919,000	158,129,000	14,362,000	-9,133,000	-6,294,000	-3,293,000	-29,108,000	-51,017,000	-37,619,000	-36,873,000	-202,990,000	-65,039,000	-100,816,000	-8,577,000	-121,311,000	-19,586,000	-19,008,000	-16,927,000	-7,467,000	-120,444,000	-29,672,000	-69,641,000	-216,229,000	-14,296,000	22,420,000	-113,283,000	-2,402,000	-43,061,000	-493,839,000	-9,843,000	-14,612,000	-22,022,000	-508,691,000	-39,197,000	-75,791,000	-2,145,000	-7,933,000	-64,177,000	-23,638,000	-4,062,000	-8,675,000	-2,905,000	6,020,000	-76,224,000
cash flows from financing activities:
proceeds from revolving credit facility	68,000,000	261,000,000	205,700,000	124,000,000	61,000,000	59,000,000	81,000,000	52,000,000	39,000,000	192,000,000	60,000,000	70,000,000	10,000,000	85,000,000	0	35,000,000	30,000,000	30,000,000	60,000,000	0	20,000,000	125,000,000	65,000,000	40,000,000	197,000,000	95,000,000	95,000,000
payments on revolving credit facility	-137,200,000	-145,000,000	-193,500,000	-49,500,000	-65,000,000	-55,500,000	-41,000,000	-43,000,000	-58,000,000	-19,000,000	-28,000,000	-60,000,000			0	-60,000,000	-35,000,000	-298,000,000	-50,000,000	-125,000,000	-15,000,000	-17,000,000	-15,000,000	-63,000,000	-13,000,000	-90,000,000	-34,000,000
payments on term loans	-75,703,000	-112,000		-75,105,000	-117,000	-105,000		-101,000	-220,100,000	-145,103,000	-98,000	-98,000	-60,094,000	-75,098,000	-43,039,000	-125,092,000	-25,091,000	-100,094,000	-42,812,000	-308,000	-305,000	-304,000	-301,000	-297,000	-293,000	-296,000	-290,000	-286,000	-283,000	-285,000		-250,199,000	-198,000	-196,000		-192,000	-192,000	-189,000		-186,000	-185,000	-183,000		-289,000	-251,000	-250,275,000
payments of debt issuance costs
payments of equity issuance costs
proceeds from issuance of common shares	58,001,000	65,483,000														0	-47,000	47,951,000						47,948,000	11,941,000	35,913,000		2,973,000				42,426,000	-25,000	79,797,000		54,000,000
noncontrolling interest capital contribution
distributions paid to noncontrolling interests
dividends paid to stockholders	-42,024,000	-41,119,000	-39,260,000	-39,099,000	-39,082,000	-39,069,000	-39,069,000	-39,069,000	-39,050,000	-39,050,000	-39,050,000	-40,190,000	-41,265,000	-41,266,000	-41,268,000	-41,266,000	-50,548,000	-49,818,000	-49,314,000	-49,227,000	-49,226,000	-46,817,000	-46,154,000	-45,525,000	-45,360,000	-42,700,000	-42,231,000	-42,172,000	-41,532,000	-39,456,000	-39,454,000	-38,935,000	-38,788,000	-35,863,000	-35,863,000	-35,239,000	-34,564,000	-32,637,000	-31,931,000	-31,931,000	-31,931,000	-28,864,000	-25,455,000	-25,452,000	-25,450,000	-24,293,000	-20,489,000	-20,490,000	-19,373,000	-24,793,000	-18,646,000	-18,074,000	-18,061,000	-24,144,000	-17,041,000	-17,042,000	-16,752,000	-17,959,000
payments of employee income taxes related to net settlement of equity awards
net cash from financing activities	-129,455,000	139,766,000	112,361,000	-46,193,000	-43,814,000	-35,922,000	-49,417,000	-30,536,000	-80,250,000	-9,516,000	-7,357,000	-112,801,000	-244,919,000	-36,177,000	-85,987,000	-191,648,000	-147,465,000	22,106,000	-54,098,000	-70,729,000	-45,019,000	58,084,000	-19,139,000			-3,156,000	51,207,000	-46,003,000	67,809,000	-28,755,000	-33,024,000	-33,629,000	-41,021,000	72,622,000	-17,596,000	23,841,000	149,399,000	-11,479,000	-66,960,000	83,387,000	-39,927,000	5,400,000	460,639,000	-25,350,000	-17,220,000	-11,921,000	482,773,000	-16,310,000	82,131,000	-24,823,000	-9,836,000	36,924,000	5,886,000	-26,144,000	-17,666,000	-17,668,000	-4,942,000	15,597,000
decrease in cash, cash equivalents and restricted cash
cash, cash equivalents and restricted cash at the beginning of the period
cash, cash equivalents and restricted cash at the end of the period
amortization of debt issuance costs, debt discounts and prepaids		1,679,000		1,504,000	1,578,000	1,440,000		1,310,000	1,034,000	1,048,000		1,060,000	1,069,000	1,087,000		1,026,000	1,063,000	1,192,000		1,425,000	1,177,000	1,173,000	1,453,000
amortization of commitment fees and note receivable discounts		-103,000	-99,000	-208,000	285,000	-94,000	-89,000	-89,000	-86,000	-148,000	-70,000	-63,000	-619,000	-120,000	-84,000	-393,000	-121,000	-131,000	-286,000	-146,000	-306,000	-129,000	-128,000	-124,000	-122,000	-119,000	-37,000	-36,000	-37,000	-552,000	-124,000	-44,000	-245,000	-104,000	-390,000
straight-line rents adjustments		-1,410,000
gains on sales of real estate		-114,000	-4,960,000	-101,000	-1,517,000	-100,000	-1,221,000	-737,000	-11,366,000	-1,397,000	0	-14,840,000	-10,521,000	-2,981,000	-6,072,000	-19,942,000				0
loan and realty losses		-14,000	745,000	3,434,000	1,106,000	10,000	-351,000				21,960,000	11,329,000	4,094,000	24,528,000	29,170,000	22,425,000			-11,000	-193,000	-360,000	1,555,000	-60,000	0	0	2,500,000	3,266,000	0																							-4,495,000
non-cash share-based compensation		2,558,000	670,000	670,000	687,000	2,155,000	865,000	866,000	769,000	2,105,000	1,037,000	1,065,000	1,428,000	5,083,000																			342,000	1,523,000
collections of mortgage and other notes receivable		19,918,000		6,345,000	5,726,000	2,621,000		1,738,000	2,282,000	7,211,000		3,100,000	113,885,000	988,000		12,243,000	51,824,000	442,000		19,316,000	291,000	14,288,000		2,008,000	258,000	300,000		865,000	240,000	2,535,000		5,870,000	12,046,000	12,109,000
acquisitions of real estate		-74,484,000		0				0	0	-38,081,000
investments in renovations of existing real estate and equipment		-2,183,000
distributions from equity method investment		415,000	0	0	236,000	166,000	555,000	0	0	2,500,000	0
equity issuance costs		-47,000									-45,000										-206,000	-87,000
distributions to noncontrolling interests		-311,000	-330,000	-288,000	-285,000	-248,000	-276,000	-366,000	-275,000	-363,000	-159,000	-235,000	-251,000	-271,000	-218,000	-290,000	-144,000	-258,000	-211,000	-239,000	-282,000	-16,000
taxes related to net settlement of equity awards		-128,000		-5,419,000
increase in cash and cash equivalents and restricted cash		110,775,000							3,747,000	-5,989,000	-10,198,000	-14,346,000	6,132,000	443,000	-10,710,000	15,470,000	-81,503,000	69,885,000		-14,304,000	-14,400,000	64,149,000		-257,000	984,000	5,642,000
cash and cash equivalents and restricted cash, beginning of period		26,502,000		0	0	24,617,000		0	0	21,516,000		0	0	39,485,000		0	0	46,343,000	0	0	0	15,669,000	0	0	0	9,912,000
cash and cash equivalents and restricted cash, end of period		137,277,000		864,000	3,574,000	13,329,000		-779,000	3,747,000	15,527,000		-14,346,000	6,132,000	39,928,000		15,470,000	-81,503,000	116,228,000	-4,771,000	-14,304,000	-14,400,000	79,818,000	-612,000	-257,000	984,000	15,554,000
adjustments to reconcile net income to net cash provided by
operating activities:
amortization of deferred loan costs, debt discounts and prepaids
straight-line lease revenue
non-cash rental income							0	0	0	-2,500,000
non-cash lease deposit liability recognized as rental income											0	0
non-cash lease incentive recognized as interest and other income
non-cash gain on equity forward
gain on note receivable payoff
loss on operations transfer											0	-19,000
loss on early retirement of debt							0	0			0	0	0	151,000	1,461,000	0	0	451,000
payment of lease incentives															0	0	0	-1,042,000	-125,000				0	-500,000	-1,350,000	-1,250,000	-2,280,000
investment in mortgage and other notes receivable																																					-20,899,000	-20,774,000	-19,157,000	-20,512,000	-11,807,000	-40,773,000	-3,008,000	-225,000	-83,000	-1,131,000	-1,369,000	-9,213,000
collection of mortgage and other notes receivable																																					11,870,000	3,985,000	2,367,000	2,363,000	14,146,000	2,619,000	106,000	351,000	100,000	899,000	97,000	3,395,000
fees received on mortgage note			0	0
acquisition of real estate											-1,488,000	0			0	0
proceeds from sales of real estate			1,521,000	0			5,489,000	2,923,000	38,418,000	10,201,000	1,000	60,064,000	95,723,000	13,170,000	35,717,000
investments in renovations of existing real estate			-6,017,000	-4,678,000	-2,746,000	-2,293,000					-497,000	-1,262,000	-2,705,000	-165,000	-459,000	-1,527,000	-36,000	-1,443,000		-5,534,000	-2,522,000	-3,057,000		-5,995,000	-4,085,000	-4,215,000		-3,143,000	-2,457,000	-1,812,000		-2,723,000	-1,897,000	-994,000
investments in equipment			-518,000	-2,027,000	-841,000	-683,000	-1,164,000								0	0	-56,000	-8,000
borrowings on term loans																																								0	0	225,000,000
payments on term loans and private placement notes
deferred loan costs
proceeds from noncontrolling interests																			0	0	0	13,000
taxes remitted on employee stock awards											0	-274,000	-7,000	-7,000						0	0	-2,705,000		-358,000	-10,000	-1,006,000		-405,000
proceeds from equity offering
payments to repurchase shares of common stock											0	-81,974,000
cash and cash equivalents and restricted cash, beginning of year
cash and cash equivalents and restricted cash, end of year
payment of lease incentive								0	0	-10,000,000
borrowings on term loan								0																																			0	0	0	130,000,000	250,000,000	0			0	0			0	0	50,000,000
debt issuance costs								0				-9,000	-63,000	-4,535,000		0	-559,000	-4,459,000						-36,000	-23,000	-67,000					-786,000				-144,000				-246,000	-57,000	-803,000	-1,502,000	456,000	-1,892,000	-86,000	-6,921,000	-4,592,000	-44,000
forward equity costs
proceeds from noncontrolling interest				0				0	922,000	2,000,000													12,000	-11,000
decrease in cash and cash equivalents and restricted cash				864,000	3,574,000	-11,288,000
(gains) losses from equity method investment											0	0
proceeds from issuance of senior notes															0	0	0	396,784,000
prepayment fee for early retirement of debt
convertible bond redemption																														-29,958,000	-46,609,000	-11,546,000
investments in existing real estate								-1,098,000	-2,244,000	-2,133,000
investment in equity method investment
gain on note payoff												0
convertible note redemption																0												0
proceeds from redeemable noncontrolling interests
distribution from equity method investment													272,000	297,000		188,000	0	288,000
straight-line rent income														-1,079,000		-3,798,000	-4,150,000	-4,241,000		-5,086,000	-5,218,000	-5,177,000		-5,720,000	-5,307,000	-5,228,000
non-cash lease deposit liability recognized as lease income														-8,838,000
income from equity method investment															-729,000	556,000	910,000	808,000	1,108,000	728,000	848,000	442,000
taxes remitted on employee stock options exercised
non-cash stock-based compensation																989,000	992,000	5,446,000		457,000	470,000	1,845,000		477,000	477,000	2,001,000	359,000	337,000	369,000	1,425,000	342,000
proceeds from sale of real estate																				0	0	39,260,000
investments in real estate																				-8,082,000	-14,295,000	-80,335,000		-8,595,000	-150,510,000	-50,122,000		0	-115,154,000	-14,404,000		-4,840,000	-10,400,000	-118,011,000
gain on sales of real estate																						-21,007,000
change in operating assets and liabilities:
investment in real estate																																					-252,147,000	-9,463,000	-2,249,000	-100,805,000	-3,251,000	-10,000	-484,817,000	-6,265,000	-13,116,000	-16,307,000	-501,897,000	-50,895,000
investment in real estate development																																					-7,914,000	-7,640,000	-5,834,000	-4,236,000	-1,369,000	-3,202,000	-2,433,000	-2,702,000	-748,000	-2,572,000	-4,043,000	-3,978,000	-2,442,000	-1,463,000
investment in renovations of existing real estate																																					-362,000	-453,000	-400,000	-941,000	-121,000	-1,695,000	-1,133,000	-1,002,000	-765,000	-1,311,000	-1,450,000	-1,987,000	-2,500,000	-836,000
equity method investment																			0	0	0	-875,000
proceeds from sale of real estate properties
proceeds from borrowings on term loans
increase in cash and cash equivalents																														167,000				853,000	635,000	321,000	-24,932,000	15,522,000	-911,000	10,904,000	-897,000	903,000									4,762,000	-5,390,000	2,873,000	-8,959,000	-6,417,000	804,000	18,433,000	-41,355,000
investments in real estate development																				-104,000												-1,455,000	-4,604,000	-3,842,000
non-cash interest income on construction loans																					-956,000	-888,000		-504,000	-457,000	-548,000		-314,000	-507,000	-436,000		-238,000	-199,000	-271,000
non-cash interest income on construction loan																																					-236,000	-150,000																	-293,000	-267,000	-221,000
loss on convertible note retirement																												0	0	738,000
gains on sales of marketable securities
proceeds from disposition of real estate properties																															0	0	0	450,000	0	0	24,723,000	3,000,000	0								-29,000								3,200,000	0	5,771,000
proceeds from sales of marketable securities																																			3,158,000	0	39,400,000	17,049,000	53,656,000												0	0			0	11,215,000	1,647,000	1,000
distributions to noncontrolling interest																																			-260,000	-439,000	-431,000	-435,000	-984,000	-439,000	-433,000	-436,000	-460,000	-724,000	-433,000	-432,000	-432,000	-377,000	-265,000	-176,000
taxes remitted in relation to employee stock options exercised																															15,000	-226,000	-244,000	-116,000	2,000	-313,000
amortization of debt issuance costs and debt discounts																									1,288,000	1,263,000
net provided by financing activities
amortization																														1,069,000	1,636,000	1,675,000	1,142,000	1,337,000	900,000	891,000	887,000	885,000	883,000	880,000	876,000	833,000	795,000	735,000	738,000	343,000	21,000
straight-line rental income																													-5,835,000	-5,962,000	-7,134,000	-6,951,000	-6,250,000	-5,755,000	-5,615,000	-6,000,000	-5,297,000	-5,286,000	-6,131,000	-6,184,000	-6,219,000	-6,089,000	-3,771,000	-4,202,000	-4,295,000	-4,195,000	-2,152,000	-1,713,000	-1,412,000	-1,283,000	-1,339,000	-1,248,000	-15,000	-1,062,000
loss on extinguishment of debt																															1,623,000	495,000
gain on disposition of equity-method investee
income from equity-method investee																																			0	754,000	58,000	402,000				229,000		53,000	-52,000	-158,000	-55,000	-178,000
payment allocated to cancellation of lease purchase option
long-term escrow deposit																																			-3,708,000	0
proceeds from exercise of stock options																																							0	0	0	1,000					0	0
distribution to acquire non-controlling interest																																			-10,538,000
gain on sale of real estate																															0	0	0	-50,000	0	0	-2,928,000	-1,654,000	0								-2,888,000								-1,049,000
gain on sale of marketable securities																																0	0	-10,038,000		0	-23,487,000	-11,000
proceeds from sale of marketable securities																																0
decrease in cash and cash equivalents																												-407,000				456,000														-5,067,000				-3,122,000
cash and cash equivalents, beginning of period																												0	0	3,063,000	-196,000	0	0	4,832,000	0	0	0	13,286,000	0	0	0	3,287,000	0	0	0	11,312,000	0	0	0	9,172,000	0	0	0	15,886,000	0	0	2,664,000	45,718,000
cash and cash equivalents, end of period																												-407,000	-185,000	3,230,000	-863,000	456,000	-2,215,000	5,685,000	635,000	321,000	-24,932,000	28,808,000	-911,000	10,904,000	-897,000	4,190,000	-272,000	-3,598,000	912,000	6,245,000	3,862,000	-29,019,000	30,419,000	6,050,000	4,762,000	-5,390,000	2,873,000	6,927,000	-6,417,000	804,000	21,097,000	4,363,000
amortization of issue costs, debt discounts and prepaid expenses
accounts payable, accrued expenses and other liabilities																													2,259,000	641,000		1,991,000	-2,023,000	2,306,000
proceeds from revolving credit facilities																													123,000,000	56,000,000
payments on revolving credit facilities																													-58,000,000	-15,000,000
offering costs																														-56,000
loan and realty losses (recoveries)
gain on sale of equity-method investee																																			0
net realized gains on sales of marketable securities																																																			0	0			-1,090,000
equity-method investment and other assets																																					-219,000	110,000	909,000	-1,433,000	106,000	634,000	-2,338,000	385,000	-29,000	-352,000	-352,000	421,000
purchases of marketable securities																																							-5,963,000
net change in borrowings under revolving credit facilities																															54,000,000	-21,000,000	1,000,000	29,000,000	29,400,000	-62,400,000	135,000,000	22,000,000	-183,000,000	116,000,000	-6,500,000	-266,500,000	293,000,000	-35,000,000	9,000,000	-60,000,000	-24,000,000	24,000,000			9,000,000	55,000,000	-95,300,000	-2,000,000
proceeds from issuance of secured debt																																							0	0	0	78,084,000	0
payments of term loans
non-cash write-offs due to lease transition
payment allocated to lease purchase option																																				0
proceeds from marketable securities																																		18,182,000
unamortized debt premium written off
write-off of debt issuance costs																																											0	0	0	2,145,000	63,000	0
share-based compensation																																			251,000	251,000	251,000	979,000	204,000	233,000	233,000	1,464,000	224,000	223,000	224,000	1,349,000	253,000	253,000	253,000	1,580,000	244,000	245,000	247,000	1,432,000	267,000	274,000	2,371,000	1,821,000
payments into facility repair escrows
payment of real estate purchase liability																																											-1,000,000	0	0	-1,600,000					-2,222,000
proceeds from convertible senior notes																																											0	0	0	200,000,000
non-cash write-offs due to lease transitions
loan recovery																																								0
equity offering costs																																								0	-75,000	-200,000
amortization of commitment fees																																					-75,000	-68,000
taxes paid on employee stock options exercised																																						-218,000
gain on purchase liability settlement
(income) income from equity-method investee
loss (income) from equity-method investee
gain on payoff of mortgage note
investment in equity-method investment
payment of earnest money deposit
change in fair value of interest rate swap agreement
receipt of earnest money deposit																																																										3,100,000
loan and realty (recoveries) losses
investment in unconsolidated entity																																																			0
repayment of term loan																																																0
principal payments on term loan																																																							-625,000	-625,000	-625,000
loan impairment																																																	0	4,037,000
real estate purchase deposit
supplemental disclosure of cash flow information:
interest paid																																																	1,212,000	1,070,000							660,000	88,000
supplemental disclosure of non-cash investing and financing activities:
conditional consideration in asset acqusition
assumption of debt in real estate acquisition
change in fair value of cash flow hedge
assignment of net assets in equity-method investee
income from unconsolidated entity																																																		-22,000
investment in unconsolidated entity and other assets																																																		-324,000
investment in mortgage notes receivable																																																			-10,444,000	-535,000	-5,210,000	-52,000	-3,200,000	-871,000	-2,496,000	-3,200,000
collection of mortgage notes receivable																																																		154,000	14,619,000	1,109,000	864,000	871,000	780,000	1,905,000	899,000	843,000
stock options exercised																																																		146,000	0				0	-1,000	200,000
supplemental schedule of non-cash investing and financing activities:
increase in fair value of cash flow hedge																																																		270,000
deferred costs and other assets																																																			-1,021,000	766,000	-226,000	56,000	354,000	455,000	-740,000	23,000
investment in real estate properties																																																			-32,861,000	-53,442,000	-19,417,000	-4,881,000	-9,455,000
proceeds from dispositions of real estate property
debt issuance costs paid																																																			-13,000
accounts receivable																																																					107,000	-189,000		919,000	-771,000	-1,512,000
straight-line rent adjustment																																																							-907,000	-945,000	-910,000
loan and realty recoveries
accounts payable and other accrued expenses																																																									-606,000
receipt of earnest money deposits																																																							0	0	525,000
net change in borrowings under a revolving credit facility																																																							0	0	-37,765,000
adjustments to reconcile net income to net cash from
benefit from loan and realty recoveries
increase in fair value of interest rate swap agreement																																																								988,000	-1,254,000
net gain on sale of real estate																																																									-2,299,000
net realized gains and recoveries on sales of marketable securities																																																									-154,000
acquisition of real estate properties																																																									-326,000	-76,968,000
national health investors, inc.
condensed consolidated statements of cash flows
supplemental schedule of non-cash activities:
settlement of mortgage note by real estate acquisition																																																										22,936,000
cash withheld at closing of real estate acquisition																																																										1,000,000
earnest money deposit applied to sale of real estate																																																									3,475,000
impairment of real estate assets in discontinued operations
realized loss on sale of marketable securities
amortization of loan costs																																																										68,000
acquisition of marketable securities
net borrowings under revolving credit facility																																																										33,935,000
credit facility fees																																																										-379,000
principal payments on debt
benefit from loan and realty losses
gain on payoff of note receivable
realized (gain) loss on sale of marketable securities
amortization of deferred income
investment in mortgage note receivable
prepayment of mortgage notes receivable
acquisition of property and equipment
proceeds from disposition of property and equipment
acquisitions of marketable securities
sales of marketable securities
net cash (used in) financing activities
supplemental information:
interest payments on bonds and notes payable
non-cash investing transactions:
real estate purchase guarantee
discount on mortgage note receivable purchased
adjustments to reconcile net income to net cash provided from operating activities:
benefit from loan, remic, realty, and security losses
net gain on sales of real estate
gain on sale of notes receivable
realized (gain) loss on sales of marketable securities
interest on debenture conversions
amortization of discount on held-to-maturity securities and real estate mortgage investment conduit
increase in accounts receivable
increase in deferred costs and other assets
increase in accounts payable and other accrued expenses
decrease in accrued interest
adjustments to reconcile net income to net cash provided from investing activities:
sale of mortgage notes receivable
collection of real estate mortgage investment conduits
acquisition of and construction of real estate properties
disposition of property and equipment
net cash from investing activities:
adjustments to reconcile net income to net cash provided from financing activities:
proceeds from debt
payments on debt
payments of convertible subordinated debentures
repurchase of common stock
sale of common stock
depreciation of real estate
benefit from loan, realty and security losses
deferred income received
amortization of bond discount
amortization of discount on investments
increase in accounts payable and accrued liabilities
payments on credit facilities
proceeds from (payments on) convertible
subordinated debentures
sale (repurchase) of cumulative convertible preferred stock
sale (repurchase) of common stock

We provide you with 20 years of cash flow statements for National Health Investors stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of National Health Investors stock. Explore the full financial landscape of National Health Investors stock with our expertly curated income statements.

The information provided in this report about National Health Investors stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.